Vitamin D, phosphate, and vasculotoxicity

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biochemistry

Background:

• Vascular calcification involves ectopic calcium-phosphate deposition, increasing morbidity and mortality in diabetes mellitus and chronic kidney disease (CKD).
• CKD patients often exhibit medial and intimal vascular calcification, linked to elevated serum calcium and phosphate levels.
• Active vitamin D metabolites are implicated in vascular mineralization, posing risks despite bone health benefits.

Purpose of the Study:

• To review the dual role of vitamin D in CKD patients.
• To explain the link between vitamin D, vascular calcification, and phosphate levels.
• To highlight strategies for minimizing vitamin-D-associated vascular pathology in CKD.

Main Methods:

• Literature review on vascular calcification mechanisms in CKD.
• Analysis of the role of vitamin D metabolites in vascular mineralization.
• Discussion of phosphate management strategies in CKD.

Main Results:

• Vitamin D supplements, while beneficial for bone, can promote vascular calcification in CKD.
• Elevated phosphate levels exacerbate vitamin-D-associated vascular pathology.
• Reducing phosphate burden is a potential strategy to mitigate vascular calcification.

Conclusions:

• Phosphate management is crucial in CKD patients undergoing vitamin D therapy.
• Minimizing phosphate levels may reduce the risk of vascular calcification.
• Further research is needed to optimize vitamin D use and phosphate control in CKD.